陳曉光，1958年生，籍貫遼寧省錦西，腫瘤藥理學家，藥物研究所研究員，博士生導師。1978年04月考入佳木斯醫學院醫療系醫學專業，1982年獲得學士學位。1985年08月在黑龍江中醫學院基礎藥理學專業攻讀碩士學位，從事心血管藥理學研究。1992年08月在北京協和醫學院藥理學專業攻讀博士學位，從事腫瘤分子藥理學研究。1995年升為助理研究員。1996年為副研究員，1999年為研究員。

主要從事抗腫瘤藥物的分子藥理學研究及新藥創制與開發，免疫調節劑的研究與開發，主要研究領域為抗腫瘤藥物研究新靶點- MEKK1、PARP1/2、PIN1、HIF-1、HSP90、IDO1/TDO、PD1/PD-L1、LAG3、NOD1/NOD2等抑制劑，PI3K、STAT3、Hedgehog等信號通路抑制劑以及與免疫調節密切相關的S1P1受體激動劑和TGF-b抑制劑等方面的研究。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Ming Ji^#, Dongjie Wang^#, Songwen Lin, Chunyang Wang, Ling Li, Zhihui Zhang, Jing Jin, Deyu Wu, Yi Dong, Heng Xu*, Duo Lu *, Xiaoguang Chen*. A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models. Acta Pharmaceutica Sinica B, 2022 February;12（2）：774-786 (IF=14.911)

2. Kehui Zhang^#, Ming Ji^#, Songwen Lin, Shouguo Peng, Zhihui Zhang, Mingyi Zhang, Jingbo Zhang, Yan Zhang, Deyu Wu, Hua Tian, Xiaoguang Chen*, and Heng Xu*. Design, Synthesis, and Biological Evaluation of a Novel Photocaged PI3K Inhibitor toward Precise Cancer Treatment. Journal of Medicinal Chemistry. 2021 64 (11), 7331-7340 (IF=8.039)

3. Jie Zhou^#, Ming Ji^#, Xiaoyu Wang, Hailong Zhao, Ran Cao, Jing ，Jin, Yan Li, Xianhong Chen, Li Sheng*, Xiaoguang Chen*, and Bailing Xu*. Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing 3-Substituted Piperizines as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. Journal of Medicinal Chemistry, 2021, 64 (22), 16711-16730 (IF=8.039)

4. Yi Dong^#, Rong Fu^#, Jiajing Chen, Kehui Zhang, Ming Ji, Mingjin Wang, Huimin Jiang, Wei Ye, Jinping Hu, Yan Li, Jing Jin, Xiaoguang Chen*, Heng Xu*. Discovery of Benzocyclic Sulfone Derivatives as Potent CXCR2 Antagonists for Cancer Immunotherapy Journal of Medicinal Chemistry. 2021 Nov 25:64(22):16626-16640. (IF=7.446)

5. Zhao Z^#, Wang X, Qu J, Zuo W, Tang Y*, Zhu H,* Chen X*. Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis. Front Oncol. 2021 Sep 15;11:708195. (IF=6.244)

6. Jing Jin^#, Nina Xue^#, Yuan Liu, Rong Fu, Mingjin Wang, Ming Ji, Fangfang Lai, Jinping Hu, Xiaojian Wang, Qiong Xiao, Xiaoying Zhang, Dali Yin,Liping Bai, Xiaoguang Chen^*, Shuan Rao^*. A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. Acta Pharmaceutica Sinica B. 2020 Feb;10(2):276-288. (IF=11.614)

7. Songwen Lin^#, Jing Jin^#, Ying Liu^#, Hua Tian, Yan Zhang, Rong Fu, Jingbo Zhang, Mingjin Wang, Tingting Du, Ming Ji, Deyu Wu, Kehui Zhang, Li Sheng, Yan Li, Xiaoguang Chen^*, Heng Xu^*. Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem. 2019 Oct 10;62(19):8873-8879. (IF=6.205)

8. Nina Xue^#, Fangfang Lai^#, Tingting Du, Ming Ji, Di Liu, Chunhong Yan, Sen Zhang, Xiaoming Yu, Jing Jin^*, Xiaoguang Chen^*. Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer. Cell Mol Life Sci. 2019 Sep;76(17):3433-3447. (IF=6.496)

9. Zhang Kehui^#, Lai Fangfang^#, Lin Songwen, Ji Ming, Zhang Jingbo, Zhang Yan, Jin Jing, Fu Rong, Wu Deyu, Tian Hua, Xue Nina, Sheng Li, Zou Xiaowen, Li Yan, Chen Xiaoguang^*, Xu Heng^*. Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases. J Med Chem. 2019 Aug 8;62(15):6992-7014. (IF=6.205)

10.Songwen Lin^#, Chunyang Wang^#, Ming Ji, Deyu Wu, Yuanhao Lv, Kehui Zhang, Yi Dong, Jing Jin, Jiajing Chen, Jingbo Zhang, Li Sheng, Yan Li, Xiaoguang Chen^*, Heng Xu^*. Discovery and Optimization of 2 Amino-4-methylquinazoline Derivatives as Highly Potent Phosphatidylinositol 3 Kinase Inhibitors for Cancer Treatment. J Med Chem. 2018 Jul 26;61(14):6087-6109. (IF=6.054)